Epigenomics (EPGNY) News Today → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free EPGNY Stock Alerts $2.39 0.00 (0.00%) (As of 04/6/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 14, 2024 | markets.businessinsider.comEQS-News: Epigenomics AG publishes financial results for fiscal year 2023January 31, 2024 | markets.businessinsider.comEQS-News: Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive BoardOctober 10, 2023 | markets.businessinsider.comEQS-Adhoc: Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023October 10, 2023 | markets.businessinsider.comEQS-News: Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company's Assets and Adjustment of Guidance for 2023September 20, 2023 | finance.yahoo.comCardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in EpigenomicsSeptember 14, 2023 | benzinga.comNew Day Diagnostics Announces Approval of Purchase Agreement by Epigenomics' AG Extraordinary General MeetingAugust 10, 2023 | markets.businessinsider.comEQS-News: Epigenomics AG publishes financial results for the first six months 2023July 24, 2023 | markets.businessinsider.comEQS-News: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant AssetsJuly 24, 2023 | finance.yahoo.comNew Day Diagnostics LLC Reinforces Commitment to Early Cancer Intervention with Its intention to Acquire the Assets of Epigenomics AGJuly 3, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of Epigenomics AG (ETR:ECX1)June 12, 2023 | marketwatch.comEpigenomics Shares Surge on Talks to Sell Nearly All Assets for $11.5 MlnMay 19, 2023 | uk.news.yahoo.comEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak ResignsMay 19, 2023 | markets.businessinsider.comEQS-News: Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak ResignsApril 13, 2023 | uk.finance.yahoo.comEpigenomics AG: Chief Executive Officer Greg Hamilton ResignsApril 12, 2023 | markets.businessinsider.comEQS-Adhoc: Epigenomics AG: Changes in the ManagementApril 12, 2023 | markets.businessinsider.comEQS-News: Epigenomics AG: Chief Executive Officer Greg Hamilton ResignsMarch 20, 2023 | uk.finance.yahoo.comEpigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation ActMarch 14, 2023 | benzinga.comSample Preparation in Genomics, Proteomics, and Epigenomics Global Market Report 2023: Increased R&D Spending in Developing Economies Boosts SectorMarch 10, 2023 | uk.finance.yahoo.comEpigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)February 21, 2023 | marketwatch.comPersonalized Medicine and Epigenomics Market Capitalizing on Market Growth: Essential Insights from Our Latest Research ReportJanuary 27, 2023 | uk.finance.yahoo.comEpigenomics AG: Resignation of Supervisory Board Chairman Heino von ProndzynskiJanuary 27, 2023 | markets.businessinsider.comEQS-News: Epigenomics AG: Resignation of Supervisory Board Chairman Heino von ProndzynskiDecember 23, 2022 | markets.businessinsider.comEQS-News: Pareto Securities AS publishes buy recommendation for Epigenomics AG shareDecember 21, 2022 | markets.businessinsider.comEQS-Adhoc: Epigenomics AG: Further raise of earnings guidance for the current fiscal year 2022December 14, 2022 | markets.businessinsider.comEQS-Adhoc: Epigenomics Releases Performance Data on Next Generation TestDecember 14, 2022 | uk.finance.yahoo.comEpigenomics Releases Performance Data on Next Generation TestDecember 14, 2022 | markets.businessinsider.comEQS-News: Epigenomics Releases Performance Data on Next Generation TestDecember 14, 2022 | markets.businessinsider.comEQS-News: Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer TestNovember 12, 2022 | yahoo.comEpigenomics Reports Third Quarter 2022 EarningsSeptember 19, 2022 | markets.businessinsider.comEQS-Adhoc: Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costsSeptember 19, 2022 | uk.finance.yahoo.comEpigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer testSeptember 19, 2022 | markets.businessinsider.comEQS-News: Epigenomics Initiates prospective multi-center clinical trial for Next-Generation blood-based colorectal cancer testSeptember 9, 2022 | markets.businessinsider.comDGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1August 15, 2022 | uk.finance.yahoo.comEpigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktGAugust 15, 2022 | markets.businessinsider.comDGAP-News: Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktGAugust 10, 2022 | markets.businessinsider.comDGAP-News: Epigenomics AG Reports Financial Results for the First Six Months of 2022May 11, 2022 | uk.finance.yahoo.comEpigenomics AG Reports Financial Results for the First Quarter of 2022May 11, 2022 | markets.businessinsider.comDGAP-News: Epigenomics AG Reports Financial Results for the First Quarter of 2022March 30, 2022 | marketwatch.comGlobal Personalized Medicine and Epigenomics Market 2022 Opportunity Assessment, Key Drivers and Challenges, Growth Rate and Forecast to 2028March 24, 2022 | markets.businessinsider.comDGAP-News: Epigenomics AG Reports Financial Results for Fiscal Year 2021January 14, 2022 | nasdaq.comEPGNY After-Hours QuotesJanuary 6, 2022 | nasdaq.comEPGNY Real-Time QuotesNovember 10, 2021 | markets.businessinsider.comDGAP-News: Epigenomics AG publishes financial results for the first nine months 2021September 13, 2021 | uk.finance.yahoo.comEpigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 millionAugust 17, 2021 | uk.finance.yahoo.comEpigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance Get Epigenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for EPGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address This could mean the end of the U.S dollar… (Ad)Experts say global conflict and escalated tensions could send the U.S. economy spiraling… Which is why elites and billionaire investors turn to physical precious metals in times like these. Download your FREE Precious Metals Guide Now. EPGNY Media Mentions By Week EPGNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPGNY News Sentiment▼0.000.51▲Average Medical News Sentiment EPGNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPGNY Articles This Week▼00▲EPGNY Articles Average Week Get Epigenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for EPGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BIAFW News IZOZF News MBGNF News MEDD News SBLOF News STRRP News WUXIF News WUXAY News TGIFF News FFNTF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EPGNY) was last updated on 5/24/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesUrgent Nvidia WarningAltimetryWrite this ticker symbol down…StocksToTrade$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyNvidia’s Quiet $1 Trillion PivotWeiss RatingsA personal note from Behind The Markets' CEO Dylan Jovine...Behind the MarketsElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Epigenomics AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
